RDH13 Antibodies

Santa Cruz Biotechnology delivers a wide array of RDH13 monoclonal antibodies for research in understanding RDH13's role in various biological processes. RDH13 monoclonal antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RDH13, or retinol dehydrogenase 13, is an enzyme involved in the metabolism of retinoids, which are crucial for vision, cellular differentiation, and embryonic development. The proper functioning of RDH13 is essential for maintaining retinoid homeostasis, and its dysregulation has been implicated in various diseases, including certain cancers and metabolic disorders. RDH13 plays a significant role in cellular processes, making it an important target for scientific investigation. Researchers can utilize RDH13 monoclonal antibodies to explore cellular pathways and mechanisms related to retinoid metabolism. Understanding RDH13's function through detailed molecular studies can reveal new therapeutic approaches for related disorders. RDH13 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of retinoid-related biological processes and disease mechanisms.